Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors

Am J Health Syst Pharm. 2003 Jul 1;60(13):1343-5. doi: 10.1093/ajhp/60.13.1343.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Aged
  • Benzimidazoles / pharmacology*
  • Benzimidazoles / therapeutic use
  • Digoxin / blood*
  • Digoxin / therapeutic use
  • Drug Interactions
  • Formularies, Hospital as Topic
  • Humans
  • Lansoprazole
  • Male
  • Omeprazole / analogs & derivatives
  • Omeprazole / therapeutic use
  • Prospective Studies
  • Proton Pump Inhibitors*
  • Rabeprazole

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Benzimidazoles
  • Proton Pump Inhibitors
  • Lansoprazole
  • Rabeprazole
  • Digoxin
  • Omeprazole